| GZFL | Guizhi Fuling Capsule |
| TCM | Traditional Chinese Medicine |
| PGF2α | prostaglandin F2α |
| PGE2 | prostaglandin E2 |
| NF-κB | nuclear factor kappa B |
| IKKβ | IκB kinase β |
| COX-2 | cyclooxygenase-2 |
| iNOS | inducible nitric oxide synthase |
| PK-PM-PD | pharmacokinetic–pharmacometabolomic–pharmacodynamic |
| EI | Efficacy Index |
| MEI | Metabolite–Efficacy Index |
| UPLC/Q-TOF-MS | ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry |
| DINA | diagnostic ion network analysis |
| PPI | protein–protein interaction |
| PCA | principal component analysis |
| PLS-DA/OPLS-DA | (orthogonal) partial least squares-discriminant analysis |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| GO | Gene Ontology |
| ROC | receiver operating characteristic |
| AUC | area under the curve |
| VIP | variable importance in projection |
| GZFL-L/GZFL-H | GZFL low-dose/high-dose |
| QC | quality control |
| H&E | hematoxylin and eosin |
| β-EP | β-endorphin |
| NO | nitric oxide |
| TNF-α | tumor necrosis factor-alpha |
| IL-6/IL-1β/IL-10 | interleukin-6/-1β/-10 |